Inequality factors in access to early-phase clinical trials in oncology in France: results of the EGALICAN-2 study

BACKGROUND: Investigation of the disparities in the access to experimental treatment in early-phase clinical trials is lacking. The objective of the EGALICAN-2 study was to identify the factors underpinning such inequalities. METHODS: A national prospective survey was conducted in 11 early-phase cli...

Descripción completa

Detalles Bibliográficos
Autores principales: Charton, E., Baldini, C., Fayet, Y., Schultz, E., Auroy, L., Vallier, E., Italiano, A., Robert, M., Coquan, E., Isambert, N., Moreau, P., Touzeau, C., Le Tourneau, C., Ghrieb, Z., Kiladjian, J.-J., Delord, J.-P., Gomez Roca, C., Vey, N., Barlesi, F., Lesimple, T., Penel, N., Soria, J.-C., Massard, C., Besle, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10415590/
https://www.ncbi.nlm.nih.gov/pubmed/37536254
http://dx.doi.org/10.1016/j.esmoop.2023.101610

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10415590/
https://www.ncbi.nlm.nih.gov/pubmed/37536254
http://dx.doi.org/10.1016/j.esmoop.2023.101610

Ejemplares similares